Filing Details

Accession Number:
0001209191-20-047575
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-19 17:43:08
Reporting Period:
2020-08-17
Accepted Time:
2020-08-19 17:43:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367920 Concert Pharmaceuticals Inc. CNCE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1618060 A. Marc Becker C/O Concert Pharmaceuticals, Inc.
65 Hayden Avenue, Suite 3000N
Lexington MA 02421
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-17 2,875 $10.24 53,434 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan.
  2. These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.